Calyx Cafe

Calyx’s Liz Dalton discusses how CROs and their partners can best work together to find the solution to the industry’s ongoing clinical development challenge: How can we move faster, yet still safely, to bring new drugs to patients faster?

Rho’s Steve Palmatier describes how partial unblinding occurs and how advanced IRT systems can reduce these very real risks to ensure data quality isn’t compromised.

Merck’s Joseph McDonnell and Jeffrey Timmons discuss the company’s spinoff of Organon, how the separate organizations are creating value for all stakeholders, and why they’re excited about the role of technology in streamlining the regulatory process.

Karen Harry explains what market authorization holders can expect as they prepare to transition their Centrally Approved Product (CAP) submissions to IDMP Iteration 1.

Hear from Willie Muehlhausen about the growing usage of BYOD, patient preferences, and what regulators have to say about this approach to collecting PRO data in clinical trials.

In this episode, Morris Panner of Ambra Health talks about first-time quality and how the continuous bursts of innovation in agile cloud technology and AI are opening opportunities to progress clinical research and enable greater access to healthcare.

By leveraging today’s data capture technologies –like advanced medical imaging –HCPs can enhance measurement quality and capture real-time data points to intervene before patients leave the site, improving clinical trial recruitment/engagement and, ultimately, patient care.